Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jun Chen

1PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 06, 2021
Efficacy and tolerability of bevacizumab in patients with severe Covid-19.

Jiaojiao Pang, Feng Xu, Gianmarco Aondio

Pageof 1

Frequent Collaborators

1 joint publications

Jiaojiao Pang

1 joint publications

Feng Xu

1 joint publications

Yu Li

1 joint publications

Alberto Fumagalli

1 joint publications

Ming Lu

1 joint publications

Yuan Bian

1 joint publications

Giovanni Damiani

1 joint publications

Yuan Zhang

1 joint publications

Dexin Yu

1 joint publications

Wenhai Sui

Frequent Collaborators

1 joint publications

Jiaojiao Pang

1 joint publications

Feng Xu

1 joint publications

Yu Li

1 joint publications

Alberto Fumagalli

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.7K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.7K
See more related videos